GlassScriptPhysician profile
Lucy H Walker
NPI 1124672209
$3,074.81
in general payments reported to CMS, 2019-2025
35 companies · $850 in 2025
The $850 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $812 · 2022: $190 · 2023: $586 · 2024: $637 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,072.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $281.73 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $255.55 | 2023-2025 | |
| Abbvie INC. | $250.82 | 2021-2024 | |
| Impulse Dynamics (USA) INC. | $241.53 | 2023-2024 | Optimizer, Optimizer |
| Pfizer INC. | $225.76 | 2021-2025 | |
| Cvrx, INC. | $164.28 | 2022-2023 | Barostim Neo System |
| Amgen INC. | $161.15 | 2022-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $153.21 | 2023-2025 | Onpattro |
| Edwards Lifesciences Corporation | $142.14 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.10 | 2021-2025 | Jardiance |
| Neos Therapeutics, LP | $113.00 | 2021 | |
| Azurity Pharmaceuticals, INC. | $85.65 | 2023-2025 | Horizant, Edarbi, Edarbi |
| Novo Nordisk INC | $82.07 | 2021 | |
| Lilly USA, LLC | $77.48 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $72.98 | 2021-2025 | Wainua |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.